SEC Filings

SEC Filings

Filing date	Description	Form	View
Nov 10, 2009	An amendment to the SC 13G filing	SC 13G/A	View HTML 0000080255-09-000577.pdf 0000080255-09-000577.rtf
Oct 29, 2009	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-09-217431.pdf 0001193125-09-217431.rtf 0001193125-09-217431.xls
Oct 27, 2009	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-09-214536.pdf 0001193125-09-214536.rtf 0001193125-09-214536.xls
Oct 23, 2009	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-09-212422.pdf 0001193125-09-212422.rtf 0001193125-09-212422.xls
Oct 13, 2009	A statement of beneficial ownership of common stock by certain persons	SC 13G	View HTML 0000053417-09-000158.pdf 0000053417-09-000158.rtf
Oct 07, 2009	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-09-204705.pdf 0001193125-09-204705.rtf 0001193125-09-204705.xls
Oct 06, 2009	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-09-203629.pdf 0001193125-09-203629.rtf 0001193125-09-203629.xls
Oct 06, 2009	A statement of beneficial ownership of common stock by certain persons	SC 13G	View HTML 0000902664-09-003662.pdf 0000902664-09-003662.rtf
Oct 06, 2009	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	424B5	View HTML 0001193125-09-204397.pdf 0001193125-09-204397.rtf 0001193125-09-204397.xls
Oct 06, 2009	Statement of changes in beneficial ownership of securities	4	View HTML 0000902664-09-003665.pdf 0000902664-09-003665.rtf

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE